|

Anti-PD-1 Monoclonal Antibody JS001 Clinical Trials

1 actively recruiting trial

Also known as: Toripalimab

Pipeline

Phase 1/2: 1

Top Sponsors

  • Xiangya Hospital of Central South University1

Indications

  • Colonic Neoplasms1
  • Chemotherapy Effect1
  • Cancer1

Other1 trial

The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.